SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-016706
Filing Date
2021-03-30
Accepted
2021-03-30 17:05:05
Documents
14
Period of Report
2021-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-8k_20210330.htm   iXBRL 8-K 43671
2 EX-99.1 crnx-ex991_6.htm EX-99.1 175491
3 GRAPHIC gagqxuuw22ie000001.jpg GRAPHIC 3697
  Complete submission text file 0001564590-21-016706.txt   371897

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA crnx-20210330.xsd EX-101.SCH 5780
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20210330_lab.xml EX-101.LAB 20227
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20210330_pre.xml EX-101.PRE 12087
7 EXTRACTED XBRL INSTANCE DOCUMENT crnx-8k_20210330_htm.xml XML 3695
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 21787519
SIC: 2834 Pharmaceutical Preparations